LAMC2 is a potential prognostic biomarker for cholangiocarcinoma.

MLA

Ong, Khaa Hoo, et al. “LAMC2 Is a Potential Prognostic Biomarker for Cholangiocarcinoma.” Oncology Letters, vol. 26, no. 6, Oct. 2023, p. 533. EBSCOhost, https://doi.org/10.3892/ol.2023.14120.

APA

Ong, K. H., Hsieh, Y.-Y., Lai, H.-Y., Sun, D.-P., Chen, T.-J., Huang, S. K.-H., Tian, Y.-F., Chou, C.-L., Shiue, Y.-L., Wu, H.-C., Chan, T.-C., Tsai, H.-H., Li, C.-F., & Kuo, Y.-H. (2023). LAMC2 is a potential prognostic biomarker for cholangiocarcinoma. Oncology Letters, 26(6), 533. https://doi.org/10.3892/ol.2023.14120

Chicago

Ong, Khaa Hoo, Yao-Yu Hsieh, Hong-Yue Lai, Ding-Ping Sun, Tzu-Ju Chen, Steven Kuan-Hua Huang, Yu-Feng Tian, et al. 2023. “LAMC2 Is a Potential Prognostic Biomarker for Cholangiocarcinoma.” Oncology Letters 26 (6): 533. doi:10.3892/ol.2023.14120.